The increased breast cancer risk after long-term use, especially before the first child that was observed in the retrospective results were not supported by the prospective analyses, neither for BRCA1-pV carriers nor for those with pV in the BRCA2 gene. This evidence concerns the gene BRCA2 and breast cancer.